Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Genomic Health Inc

+ Add to Watchlist

GHDX:US

32.2800 USD 0.1000 0.31%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Genomic Health Inc (GHDX)

Open: 32.2100 Day's Range: 32.2100 - 33.6639 Volume: 154,212
Previous Close: 32.3800 52wk Range: 23.9000 - 37.7450 1-Yr Rtn: +7.17%

Stock Chart for GHDX

No chart data available.
  • GHDX:US 32.2800
  • 1D
  • 1M
  • 1Y
32.3800
Interactive GHDX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GHDX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8796
Est. EPS (USD) (12/2014) -0.8120
Est. PEG Ratio -
Market Cap (M USD) 1,023.97
Shares Outstanding (M) 31.72
30 Day Average Volume 158,396
Price/Book (mrq) 7.1293
Price/Sale (ttm) 3.6604
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GHDX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GHDX

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company's diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.

Kimberly J Popovits "Kim"Chairman/President/CEOG Bradley ColeCFO/COO/Secretary
Steven ShakExec VP:Research & Dev
More Company Profile & Key Executives for GHDX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil